跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Compound 18
首页
药物
Compound 18
Experimental
Small Molecule
Compound 18
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
27
H
29
NO
4
S
CAS 编号
31112-66-0
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FGF-18 COMPOUND DOSING REGIMEN
申请人: MERCK PATENT GMBH
优先权: 2014
CN
EP
US
WO
10 件公开
Combination composition comprising FGF-18 compound
申请人: MERCK PATENT GMBH
优先权: 2015
CN
18-macrolide epothilone compound and application thereof
申请人: UNIV SHANDONG
优先权: 2010
CN
Method for preparing F-18 labeled compound
申请人: SHANGHAI INST ORGANIC CHEMISTRY CAS
优先权: 2024
CN
Development of membrane anchoring type DR-18 compound and application of membrane anchoring type DR-18 compound in immune cell therapy
申请人: YIJISHAN HOSPITAL WANNAN MEDICAL COLLEGE
优先权: 2023
CN
Inflammatory biomarkers for predicting responsiveness to FGF-18 compound
申请人: MERCK PATENT GMBH
优先权: 2018
US
2 件公开
Metabolic biomarkers for predicting responsiveness to FGF-18 compound
申请人: MERCK PATENT GMBH
优先权: 2017
CN
US
3 件公开
18 compound amino acid injection and its preparing method
申请人: YU FENG
优先权: 2004
CN
药物
反馈